Akers Biosciences in equity issue

Akers Biosciences has issued 9,366,668 common shares after receiving applications for the conversion of 1,405 shares of series B convertible preferred stock with a stated value of $1,000 per share.

At 9:16am: (LON:AKR) Akers Biosciences Inc share price was 0p at 17p